Search





Search





BridgeBio Pharma Inc

BBIO

Add to Watchlist

66.610USD

-0.700-1.04%

Close 09-18 16:00（ET）

13.01BMarket Cap

LossP/E TTM

BridgeBio Pharma Inc

66.610

-0.700-1.04%

Financial Summary Income Statement Balance Sheet Cash Flow Statement Revenue Earnings Company Valuation Risk Assessment

Overview

News&Analysis

Financials

Stock Score

Technical

Forecast

Ownership

Dividends

Profile

Discussions

Financial Summary Income Statement Balance Sheet Cash Flow Statement Revenue Earnings Company Valuation Risk Assessment

BBIO Cash Flow Statement

You can access the annual and quarterly cash flow statements of BridgeBio Pharma Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q1

Operating cash flows (indirect method)

Cash flow from continuing operating activities

11.87%-71.10M

0.98%-197.28M

71.11%-56.42M

39.32%-109.57M

-208.00%-80.68M

9.25%-199.24M

-56.49%-195.33M

-24.33%-180.57M

165.90%74.70M

-52.12%-219.54M

-33.86%-124.82M

-7.45%-145.23M

-272.22%-113.35M

10.16%-144.32M

30.36%-93.24M

-11.19%-135.16M

66.80%-30.45M

-6.55%-160.63M

-39.10%-133.90M

7.69%-121.56M

-4.40%-91.71M

-79.65%-150.76M

-26.32%-96.26M

-163.39%-131.68M

-28.72%-87.85M

-41.90%-83.92M

---76.20M

---50.00M

---68.25M

-229.45%-59.14M

---17.95M

Net income from continuing operations

15.17%-155.89M

1.80%-166.56M

27.21%-194.63M

-12.59%-184.94M

-143.25%-183.76M

-369.05%-169.61M

-56.98%-267.39M

8.49%-164.25M

52.99%-75.54M

74.67%-36.16M

-21.17%-170.33M

-28.03%-179.49M

-6179.91%-160.70M

29.11%-142.73M

7.69%-140.57M

12.93%-140.19M

97.49%-2.56M

-17.68%-201.33M

-12.78%-152.28M

-23.70%-161.02M

25.06%-102.07M

-64.37%-171.08M

-60.46%-135.03M

-114.33%-130.17M

-83.42%-136.21M

-49.90%-104.08M

---84.15M

---60.73M

---74.27M

-63.65%-69.44M

---42.43M

Operating gains losses

-20.05%1.05M

-7.63%1.19M

4.97%1.44M

-9.10%1.40M

-16.33%1.32M

-19.55%1.28M

-13.75%1.37M

-6.16%1.54M

-3.85%1.57M

-2.27%1.60M

-4.52%1.58M

-0.36%1.64M

3.48%1.64M

-13.32%1.63M

8.78%1.66M

-61.89%1.65M

-60.96%1.58M

--1.88M

--1.53M

--4.32M

--4.05M

----

--374.00K

--132.00K

330.77%112.00K

--26.00K

Other non-cash items

-82.54%4.75M

-91.80%3.59M

-77.34%2.48M

149.56%24.50M

121.40%27.21M

39.97%43.82M

76.70%10.93M

-1570.35%-49.43M

-2086.31%-127.14M

309.97%31.30M

-63.35%6.18M

6.59%3.36M

106.04%6.40M

35.46%7.64M

451.36%16.88M

15.83%3.15M

-5031.08%-105.97M

-26.89%5.64M

-72.84%3.06M

-73.25%2.72M

-67.76%2.15M

175.85%7.71M

1082.58%11.27M

613.31%10.18M

685.97%6.67M

8.59%2.79M

--953.00K

--1.43M

--848.00K

-84.98%2.57M

--17.14M

Change in working capital

-147.85%-9.29M

-7.38%-124.74M

283.24%49.61M

-83.52%-3.93M

-92.12%19.42M

48.42%-116.17M

-41.10%12.95M

-263.39%-2.14M

1716.18%246.44M

-608.13%-225.20M

87.09%21.98M

119.08%1.31M

-59.22%13.57M

-733.82%-31.80M

-50.93%11.75M

-141.97%-6.87M

228.23%33.28M

75.27%-3.81M

59.64%23.94M

155.85%16.37M

-220.31%-25.95M

-300.68%-15.42M

483.33%15.00M

-794.36%-29.32M

823.13%21.57M

1135.58%7.68M

---3.91M

---3.28M

---2.98M

-112.07%-742.00K

--6.14M

-Change in receivables

-228.29%-49.26M

40.49%-65.78M

-440.20%-22.93M

-21885.71%-39.65M

-83.65%38.40M

52.71%-110.54M

-224.13%-4.24M

-94.71%182.00K

10832.68%234.83M

-3799.64%-233.74M

-78.63%3.42M

190.01%3.44M

129.53%2.15M

-38.46%6.32M

238.21%16.00M

-110.28%-3.83M

83.80%-7.27M

2322.08%10.27M

-244.71%-11.58M

821.49%37.19M

---44.90M

---462.00K

--8.00M

---5.16M

----

-Change in inventory

-57.69%-21.11M

-120.89%-7.05M

---1.95M

---6.77M

---13.39M

---3.19M

----

-Change in prepaid expenses

93.79%-1.38M

-3769.61%-18.84M

141.38%8.75M

147.28%5.22M

-604.14%-22.26M

85.44%-487.00K

310.51%3.63M

-441.83%-11.04M

-168.73%-3.16M

5.56%-3.34M

-147.85%-1.72M

-128.72%-2.04M

1363.46%4.60M

-33.31%-3.54M

793.45%3.60M

237.92%7.09M

-658.33%-364.00K

-283.49%-2.66M

68.88%-519.00K

26.79%-5.14M

96.04%-48.00K

-49.12%1.45M

-75.39%-1.67M

23.61%-7.03M

60.08%-1.21M

1021.04%2.85M

---951.00K

---9.20M

---3.04M

81.53%-309.00K

---1.67M

-Change in other current assets

15.50%-1.49M

-213.11%-1.79M

-72.34%545.00K

154.16%742.00K

-453.61%-1.76M

257.43%1.59M

165.91%1.97M

-197.09%-1.37M

-3.30%498.00K

191.93%444.00K

-441.21%-2.99M

0.50%1.41M

-34.81%515.00K

-103.41%-483.00K

198.87%876.00K

143.78%1.40M

102.56%790.00K

331.67%14.16M

54.61%-886.00K

-515.95%-3.21M

268.83%390.00K

-732.83%-6.11M

87.21%-1.95M

86.68%771.00K

-2.67%-231.00K

60.37%-734.00K

---15.27M

--413.00K

---225.00K

-83.37%-1.85M

---1.01M

-Change in other current liabilities

50.99%-1.92M

7.47%-2.38M

-249.85%-1.95M

-79.95%-2.99M

-119.24%-3.92M

-110.70%-2.57M

233.47%1.30M

-29.77%-1.66M

-24.51%-1.79M

1474.37%24.02M

42.94%-974.00K

-490.24%-1.28M

-108.63%-1.44M

---1.75M

-151.15%-1.71M

--328.00K

--16.64M

----

--3.34M

----

--0.00

--83.00K

---34.00K

-172.61%-114.00K

--157.00K

Cash from non-recurring investing activities

Cash from operating activities

11.87%-71.10M

0.98%-197.28M

71.11%-56.42M

39.32%-109.57M

-208.00%-80.68M

9.25%-199.24M

-56.49%-195.33M

-24.33%-180.57M

165.90%74.70M

-52.12%-219.54M

-33.86%-124.82M

-7.45%-145.23M

-272.22%-113.35M

10.16%-144.32M

30.36%-93.24M

-11.19%-135.16M

66.80%-30.45M

-6.55%-160.63M

-39.10%-133.90M

7.69%-121.56M

-4.40%-91.71M

-79.65%-150.76M

-26.32%-96.26M

-163.39%-131.68M

-28.72%-87.85M

-41.90%-83.92M

---76.20M

---50.00M

---68.25M

-229.45%-59.14M

---17.95M

Investing cash flow

Net cash from continuing investing activities

-91.30%443.00K

-95.67%69.00K

-98.98%33.00K

65.70%2.87M

108.17%5.09M

6.90%1.59M

644.14%3.24M

301.86%1.73M

471.73%2.45M

12333.33%1.49M

-45.69%435.00K

-43.21%431.00K

-89.03%428.00K

100.13%12.00K

-68.41%801.00K

-88.25%759.00K

70.62%3.90M

-566.14%-9.14M

18.17%2.54M

1077.05%6.46M

1049.25%2.29M

-56.20%1.96M

22.84%2.15M

44.09%549.00K

-65.87%199.00K

84.47%4.48M

--1.75M

--381.00K

--583.00K

-84.01%2.43M

--15.18M

Capital expenditures

-91.30%443.00K

-95.67%69.00K

-98.98%33.00K

65.70%2.87M

108.17%5.09M

6.90%1.59M

644.14%3.24M

301.86%1.73M

471.73%2.45M

12333.33%1.49M

-45.69%435.00K

-43.21%431.00K

-89.03%428.00K

-98.60%12.00K

-68.41%801.00K

-88.25%759.00K

70.62%3.90M

-56.20%859.00K

18.17%2.54M

1077.05%6.46M

560.98%2.29M

-56.20%1.96M

22.84%2.15M

44.09%549.00K

-40.65%346.00K

84.47%4.48M

--1.75M

--381.00K

--583.00K

-84.01%2.43M

--15.18M

Net cash flow from disposal of fixed assets

-25.42%443.00K

--69.00K

-29.79%33.00K

243.07%470.00K

1000.00%594.00K

-100.00%0.00

-89.20%47.00K

-68.21%137.00K

-87.38%54.00K

5691.67%695.00K

-45.69%435.00K

-43.21%431.00K

-89.03%428.00K

100.13%12.00K

-68.41%801.00K

-88.25%759.00K

70.62%3.90M

-566.14%-9.14M

18.17%2.54M

1077.05%6.46M

1049.25%2.29M

-56.20%1.96M

22.84%2.15M

44.09%549.00K

139.76%199.00K

948.48%4.48M

--1.75M

--381.00K

--83.00K

141.24%427.00K

--177.00K

Net cash flow from intangible asset transactions

----

-100.00%0.00

50.47%2.40M

88.05%4.50M

100.13%1.59M

--3.19M

--1.59M

--2.39M

--797.00K

----

-100.00%0.00

--0.00

--500.00K

-86.67%2.00M

--15.00M

Net cash flow from business transactions

----

--0.00

---35.00M

----

--0.00

--784.00K

----

Net cash flow from investment products

331.78%18.33M

---42.67M

---14.32M

-87.42%5.03M

-241.62%-7.91M

100.00%0.00

-100.00%0.00

4.95%40.00M

22.81%5.58M

-111.22%-1.44M

-98.03%369.00K

-74.18%38.11M

-97.04%4.55M

-90.10%12.81M

-22.89%18.77M

83.53%147.62M

1508.05%153.60M

146.23%129.48M

-73.57%24.34M

280.74%80.43M

91.53%-10.91M

-759.04%-280.09M

707.57%92.07M

77.50%-44.50M

---128.78M

--42.50M

---15.15M

---197.75M

----

Net cash flow from other investing activities

----

--0.00

5580.95%2.30M

100.00%0.00

-100.00%0.00

--0.00

---42.00K

---98.00K

5205.77%25.68M

--0.00

---503.00K

--0.00

-100.00%0.00

----

100.00%0.00

--20.00M

--13.65M

----

---6.91M

----

--0.00

----

Cash from non-current investing activities

Net cash flow from investing activities

237.56%17.89M

-2579.31%-42.73M

-343.44%-14.35M

-88.32%4.46M

-527.84%-13.00M

-107.01%-1.59M

-4804.55%-3.24M

1.44%38.23M

-26.22%3.04M

85.01%22.75M

-100.37%-66.00K

-74.34%37.68M

-97.25%4.12M

-91.13%12.30M

-17.59%17.96M

149.05%146.86M

32586.03%149.70M

149.15%138.62M

-73.74%21.80M

230.89%58.97M

100.36%458.00K

-841.79%-282.05M

591.20%83.02M

77.17%-45.05M

-22024.19%-128.98M

1666.67%38.02M

---16.90M

---197.34M

---583.00K

84.01%-2.43M

---15.18M

Financing cash flow

Cash flow from continuous financing activities

-149.25%-148.77M

811.50%549.89M

-100.46%-2.18M

-226.45%-894.00K

5372.14%302.04M

-78.42%60.33M

10578.24%473.93M

-99.77%707.00K

-365.39%-5.73M

86.06%279.55M

-170.93%-4.52M

21148.44%307.04M

94.08%-1.23M

94005.63%150.25M

-98.04%6.38M

101.07%1.45M

-1395.04%-20.80M

-100.03%-160.00K

7081.22%325.38M

-4969.02%-135.46M

-297.87%-1.39M

24.76%547.91M

-89.44%4.53M

-99.24%2.78M

107.05%703.00K

26700.42%439.17M

--42.90M

--367.51M

---9.97M

-110.52%-1.65M

--15.69M

Net cash flow from debt Issuance/repayment

---431.00K

434.23%619.70M

-100.00%0.00

--0.00

595.37%116.00M

--472.49M

--0.00

---23.42M

--0.00

100.00%0.00

----

-100.00%0.00

--0.00

-397.24%-20.49M

-100.00%0.00

--325.29M

--0.00

--6.89M

35.91%747.50M

-100.00%0.00

--0.00

-100.00%0.00

307162.57%550.00M

--17.15M

--0.00

--19.79M

-94.82%179.00K

--3.46M

Net cash flow from common stock issuance/repurchase

---127.50M

-70.89%-82.50M

--0.00

-115.31%-48.28M

100.00%0.00

----

120.43%315.25M

-109.36%-454.00K

--306.21M

--1.03M

--143.02M

414.66%4.85M

100.00%0.00

---1.54M

---143.15M

---5.31M

33.33%-50.00M

--0.00

-100.00%0.00

--0.00

---75.00M

--0.00

--389.55M

----

Net cash flow from preferred stock issuance/repurchase

----

--0.00

----

Proceeds from stock option exercised by employees

-27.04%5.22M

387.24%28.05M

363.90%13.21M

269.93%8.02M

2870.54%7.16M

98.48%5.76M

261.88%2.85M

-66.64%2.17M

102.52%241.00K

44.91%2.90M

1280.70%787.00K

218.37%6.50M

112.50%119.00K

87.10%2.00M

-97.57%57.00K

-61.10%2.04M

-98.51%56.00K

-88.26%1.07M

-76.51%2.35M

159.11%5.25M

174.47%3.75M

1141.96%9.12M

448.05%10.00M

485.26%2.02M

214.25%1.37M

612.62%734.00K

--1.82M

--346.00K

--435.00K

171.05%103.00K

--38.00K

Net cash flow from other financing activities

-108.86%-26.06M

-10.13%-15.37M

-1039.17%-15.99M

-510.13%-8.91M

5026.83%294.13M

8.14%-13.95M

45.05%-1.40M

79.63%-1.46M

-150.52%-5.97M

-390.38%-15.19M

-274.05%-2.56M

-1103.52%-7.17M

-551.09%-2.38M

525.28%5.23M

306.47%1.47M

18.69%-596.00K

83.95%-366.00K

98.43%-1.23M

-50.96%-711.00K

-201.65%-733.00K

-243.52%-2.28M

-27.13%-78.38M

---471.00K

-109.72%-243.00K

57.52%-664.00K

-6487.07%-61.66M

----

--2.50M

---1.56M

---936.00K

--0.00

Net cash from non-recurrent financing activities

Net cash from financing activities

-149.25%-148.77M

811.50%549.89M

-100.46%-2.18M

-226.45%-894.00K

5372.14%302.04M

-78.42%60.33M

10578.24%473.93M

-99.77%707.00K

-365.39%-5.73M

86.06%279.55M

-170.93%-4.52M

21148.44%307.04M

94.08%-1.23M

94005.63%150.25M

-98.04%6.38M

101.07%1.45M

-1395.04%-20.80M

-100.03%-160.00K

7081.22%325.38M

-4969.02%-135.46M

-297.87%-1.39M

24.76%547.91M

-89.44%4.53M

-99.24%2.78M

107.05%703.00K

26700.42%439.17M

--42.90M

--367.51M

---9.97M

-110.52%-1.65M

--15.69M

Net cash flow

Beginning cash balance

62.51%882.02M

-16.26%572.14M

58.16%645.10M

-100.00%0.00

13.66%542.74M

73.09%683.24M

-22.18%407.88M

69.27%549.51M

9.74%477.50M

-5.31%394.73M

7.90%524.14M

-31.31%324.64M

16.28%435.11M

5.18%416.88M

165.34%485.79M

24.01%472.65M

-21.02%374.19M

10.51%396.37M

-50.17%183.08M

-29.60%381.13M

-37.45%473.77M

-1.52%358.68M

-11.34%367.39M

83.99%541.34M

103.06%757.47M

-16.52%364.20M

--414.40M

--294.23M

--373.03M

372.25%436.25M

--92.38M

Current period cash flow changes

-196.94%-201.98M

320.55%309.88M

-126.49%-72.96M

25.16%-106.00M

189.33%208.36M

-269.76%-140.50M

312.79%275.37M

-171.00%-141.63M

165.19%72.01M

354.12%82.76M

-87.82%-129.41M

1418.35%199.50M

-212.20%-110.47M

182.20%18.23M

-132.30%-68.90M

106.63%13.14M

206.27%98.45M

-119.26%-22.17M

2548.19%213.29M

-13.85%-198.05M

57.13%-92.65M

-70.73%115.09M

82.65%-8.71M

-244.75%-173.95M

-174.28%-216.13M

722.09%393.28M

---50.20M

--120.17M

---78.80M

-262.59%-63.22M

---17.43M

Ending cash balance

-9.46%680.04M

62.51%882.02M

-16.26%572.14M

-125.99%-106.00M

36.69%751.10M

13.66%542.74M

73.09%683.24M

-22.18%407.88M

69.27%549.51M

9.74%477.50M

-5.31%394.73M

7.90%524.14M

-31.31%324.64M

16.28%435.11M

5.18%416.88M

165.34%485.79M

24.01%472.65M

-21.02%374.19M

10.51%396.37M

-50.17%183.08M

-29.60%381.13M

-37.45%473.77M

-1.52%358.68M

-11.34%367.39M

83.99%541.34M

103.06%757.47M

--364.20M

--414.40M

--294.23M

397.76%373.03M

--74.94M

Free cash flow

16.59%-71.54M

1.73%-197.35M

71.57%-56.45M

38.32%-112.44M

-218.71%-85.78M

9.14%-200.83M

-58.53%-198.56M

-25.16%-182.30M

163.50%72.26M

-53.14%-221.03M

-33.19%-125.25M

-7.16%-145.66M

-231.19%-113.78M

10.63%-144.33M

31.07%-94.04M

-6.17%-135.92M

63.45%-34.35M

-5.74%-161.49M

-38.64%-136.43M

3.18%-128.02M

-6.58%-94.00M

-72.77%-152.73M

-26.24%-98.41M

-162.49%-132.23M

-28.13%-88.19M

-43.58%-88.40M

---77.95M

---50.38M

---68.83M

-85.85%-61.57M

---33.13M

Currency unit

--USD

Audit opinions

----

FAQs

What is operating cash flow?



Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did BridgeBio Pharma Inc Generate?



BridgeBio Pharma Inc generated -445.91M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did BridgeBio Pharma Inc's Operating Cash Flow Change Year Over Year?



BridgeBio Pharma Inc's operating cash flow increased by 14.37% year over year.

What is investing cash flow?



Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does BridgeBio Pharma Inc Spend on Capital Expenditures?



BridgeBio Pharma Inc spent 9.59M on capital expenditures in the most recent quarter。

What is financing cash flow?



Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has BridgeBio Pharma Inc's Financing Cash Flow Changed?



BridgeBio Pharma Inc used 359.29M in financing activities in the latest quarter.

What is free cash flow and why does it matter for BBIO?



Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was BridgeBio Pharma Inc’s free cash flow in the latest quarter?



Free cash flow was -455.50M reflecting a 14.00% change from the previous year.